Antithymocyte antisera globulin effect on human lymphoid neoplasia.
D000328:Adult; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006041:Goats / Q000276:immunology; D006084:Graft Rejection; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy*; D007273:Injections, Intramuscular; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007958:Leukocyte Count; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000188:drug therapy; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000276:immunology*; D014182:Transplantation, Autologous; D014605:Uveitis / Q000188:drug therapy; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D000961:Antilymphocyte Serum